Zobrazeno 1 - 10
of 16
pro vyhledávání: '"alk-positive adenocarcinoma"'
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 34, Iss , Pp 102063- (2024)
Purpose: This report details the characteristics of a case of bilateral optic neuropathy during treatment with oral lorlatinib for ALK-positive metastatic adenocarcinoma of the lung. Observations: A 57-year-old woman with metastatic adenocarcinoma of
Externí odkaz:
https://doaj.org/article/71b915d0f7ba4ba6846792c47833cd96
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hélène Roussel, Eléonore De Guillebon, Lucie Biard, Marion Mandavit, Laure Gibault, Elisabeth Fabre, Martine Antoine, Paul Hofman, Michèle Beau-Faller, Hélène Blons, Claire Danel, Françoise Le Pimpec Barthes, Alain Gey, Clémence Granier, Marie Wislez, Pierre Laurent-Puig, Stéphane Oudard, Patrick Bruneval, Cécile Badoual, Jacques Cadranel, Eric Tartour
Publikováno v:
OncoImmunology, Vol 6, Iss 4 (2017)
Anaplastic lymphoma kinase (ALK) inhibitors have been successfully developed for non-small cell lung carcinoma (NSCLC) displaying chromosomal rearrangements of the ALK gene, but unfortunately resistance invariably occurs. Blockade of the PD-1-PD-L1/2
Externí odkaz:
https://doaj.org/article/af488e65aaea4236b718d1002a0526e5
Publikováno v:
Cureus
Non-small-cell lung cancer (NSCLC) is the most common non-AIDS defining cancer in patients infected with HIV and has the highest mortality rate among all cancers in this patient population. Treatment of NSCLC in HIV-positive patients is similar to th
Autor:
Rovel J Colaco, Yee Pei Song
Publikováno v:
Cureus
Stereotactic radiosurgery (SRS) provides excellent control in the treatment of brain metastases (BM). The use of newer, targeted and immunotherapy treatments have resulted in improved overall survival in patients even with an extensive metastatic dis
Publikováno v:
Cureus
Epidermal growth factor receptor (EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) rearrangements are now routine biomarkers that have been incorporated into the practice of managing non-small cell lung cancer (NSCLC). Historically, th
Publikováno v:
Cureus
This report describes the case of a 15-year-old male diagnosed with primary ALK-positive adenocarcinoma of the lung metastatic to the brain. He was treated with surgical resection for a single lesion followed by whole brain radiotherapy and subsequen
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pichardo R; Internal Medicine, John H Stroger Jr. Hospital of Cook County, Chicago, USA., Go RF; Internal Medicine, John H Stroger Jr. Hospital of Cook County, Chicago, USA., Qu L; Internal Medicine, West China School of Medicine, Sichuan University, Chengdu, CHN., Hussein L; Hematology / Oncology, John H Stroger Jr. Hospital of Cook County, Chicago, USA., Gupta S; Hematology / Oncology, John H Stroger, Jr. Hospital of Cook County, Chicago, USA.
Publikováno v:
Cureus [Cureus] 2019 Aug 22; Vol. 11 (8), pp. e5466. Date of Electronic Publication: 2019 Aug 22.